Description
Recombinant monoclonal antibody to CD8 (Lyt-2.2). Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma 2.43.
Target
CD8 (Lyt-2.2)
Target Alias Names
Lyt 2.2, T-cell surface glycoprotein CD8 alpha chain, Cd8a, T-cell surface glycoprotein Lyt-2, lyt-2, lyt2, CD_antigen: CD8a, 2.43.1
Isotype/Mimetic
IgG2b
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression